Correlation Between Unicycive Therapeutics and Vor Biopharma
Can any of the company-specific risk be diversified away by investing in both Unicycive Therapeutics and Vor Biopharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Unicycive Therapeutics and Vor Biopharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Unicycive Therapeutics and Vor Biopharma, you can compare the effects of market volatilities on Unicycive Therapeutics and Vor Biopharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Unicycive Therapeutics with a short position of Vor Biopharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Unicycive Therapeutics and Vor Biopharma.
Diversification Opportunities for Unicycive Therapeutics and Vor Biopharma
0.37 | Correlation Coefficient |
Weak diversification
The 3 months correlation between Unicycive and Vor is 0.37. Overlapping area represents the amount of risk that can be diversified away by holding Unicycive Therapeutics and Vor Biopharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Vor Biopharma and Unicycive Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Unicycive Therapeutics are associated (or correlated) with Vor Biopharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Vor Biopharma has no effect on the direction of Unicycive Therapeutics i.e., Unicycive Therapeutics and Vor Biopharma go up and down completely randomly.
Pair Corralation between Unicycive Therapeutics and Vor Biopharma
Given the investment horizon of 90 days Unicycive Therapeutics is expected to generate 1.0 times more return on investment than Vor Biopharma. However, Unicycive Therapeutics is 1.0 times less risky than Vor Biopharma. It trades about 0.23 of its potential returns per unit of risk. Vor Biopharma is currently generating about 0.01 per unit of risk. If you would invest 38.00 in Unicycive Therapeutics on September 12, 2024 and sell it today you would earn a total of 42.00 from holding Unicycive Therapeutics or generate 110.53% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Unicycive Therapeutics vs. Vor Biopharma
Performance |
| Timeline |
| Unicycive Therapeutics |
| Vor Biopharma |
Unicycive Therapeutics and Vor Biopharma Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Unicycive Therapeutics and Vor Biopharma
The main advantage of trading using opposite Unicycive Therapeutics and Vor Biopharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Unicycive Therapeutics position performs unexpectedly, Vor Biopharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Vor Biopharma will offset losses from the drop in Vor Biopharma's long position.| Unicycive Therapeutics vs. Transcode Therapeutics | Unicycive Therapeutics vs. Cardio Diagnostics Holdings |
| Vor Biopharma vs. Monte Rosa Therapeutics | Vor Biopharma vs. Design Therapeutics | Vor Biopharma vs. Erasca Inc | Vor Biopharma vs. Edgewise Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Stock Tickers module to use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites.
Other Complementary Tools
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals |